ENZYME THERAPY IN MASTOPATHY

Citation
E. Rammer et F. Friedrich, ENZYME THERAPY IN MASTOPATHY, Wiener Klinische Wochenschrift, 108(6), 1996, pp. 180-183
Citations number
8
Categorie Soggetti
Medicine, General & Internal
ISSN journal
00435325
Volume
108
Issue
6
Year of publication
1996
Pages
180 - 183
Database
ISI
SICI code
0043-5325(1996)108:6<180:ETIM>2.0.ZU;2-A
Abstract
In this randomized double-blind clinical study the efficacy of an enzy me preparation (Wobenzym(R)) was compared with hormone therapy (Lynest renol) in 29 women with mastopathy. There was a significantly greater decrease in number of hardenings of the mammary gland after 2 months o f enzyme therapy than Lynestrenol therapy: improvement in the former g roup was 100%, in the latter group 78.6%. No significant difference wa s observed regarding the numbers of lumps, or number and size of cysts , sensitivity to touch, feeling of tension, spontaneous pain, and pain on pressure. The efficacy of both medicines is valued as good. Wobenz ym(R) therapy was tolerated very well. No side effects appeared at all . Enzyme therapy is an alternative, low-risk therapy for the managemen t of mastopathy, which does not interfere with the alsready upset horm onal balance of the patients.